Northwestern Mutual Wealth Management
DAWN

Northwestern Mutual Wealth Management’s Day One Biopharmaceuticals DAWN Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-14
Closed -$231 – 3556
2024
Q1 		$231 Buy
+14
New +$210 ﹤0.01% 3386
2023
Q4 		– Sell
-15
Closed -$184 – 3511
2023
Q3 		$184 Buy
+15
New +$196 ﹤0.01% 3184
2023
Q2 		– Sell
-13
Closed -$174 – 3393
2023
Q1 		$174 Buy
13
+6
+86% +$117 ﹤0.01% 3198
2022
Q4 		$151 Buy
+7
New +$144 ﹤0.01% 3201

Other funds holding DAWN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Northwestern Mutual Wealth Management's DAWN Position: Q2 2024 in Review

Northwestern Mutual Wealth Management sold out of Day One Biopharmaceuticals (DAWN) in Q2 2024, closing a stake of 14 shares — an estimated $231 sold.

Northwestern Mutual Wealth Management first reported a position in DAWN in Q4 2022 and held it in 4 quarters. The position peaked at $231 in Q1 2024. 156 funds tracked by Wall St. Rank hold DAWN as of Q2 2024.

  • Northwestern Mutual Wealth Management reported no remaining Day One Biopharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 14 Day One Biopharmaceuticals shares in Q2 2024, an estimated $231.
  • Northwestern Mutual Wealth Management first reported a position in Day One Biopharmaceuticals in Q4 2022 and held it in 4 quarters.
  • Northwestern Mutual Wealth Management's Day One Biopharmaceuticals position peaked at $231 in Q1 2024.
  • 156 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2024.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2024, filed 16 Aug 2024.